Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Strategies to modulate the immune system by inducing regulatory T cells (Tregs) and shifting the balance of helper T cell responses from a Th2-dominated profile to a Th1-dominated profile. This approach aims to restore immune homeostasis, suppress autoimmunity, improve responses to intracellular pathogens, and modulate allergic reactions. Key components include Treg induction/expansion and manipulating cytokine signaling pathways to favor Th1 differentiation.
Induction or expansion of regulatory T cells, shift from Th2 to Th1 response via cytokine modulation and signaling pathway activation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Modulation via Induction of Regulatory T Cells and Shift from Th2 to Th1 Response (Treg/Th1 Modulation).